MicroGenDX First Independent Commercial Lab in US Offering NGS for Infections to Appeal Directly to Patients
January 24, 2022 18:07 ET
|
Microgen Diagnostics
ORLANDO, Fla., Jan. 24, 2022 (GLOBE NEWSWIRE) -- Using national TV, radio, and web media campaigns, Microgen Diagnostics will be the first independent commercial lab in the U.S. to appeal directly...
What's Wrong Wellness: One Mother's Chilling Medical Discovery That Could Be Impacting Many Families
September 30, 2021 06:00 ET
|
What's Wrong Wellness
NASHVILLE, Tenn., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Morgan James Publishing's new release What's Wrong With My Child?: One Mother's Desperate Quest to Uncover What Was Really Wrong With Her Family...
CRMD BREAKING NEWS: ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages CorMedix Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CRMD
August 17, 2021 12:03 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CorMedix Inc. (NASDAQ: CRMD) between July 8, 2020 and...
DEINOVE is now ready to start Phase II clinical trial for its antibiotic compound DNV3837
May 16, 2019 12:30 ET
|
Deinove
DEINOVE is now ready to start Phase II clinical trial for its antibiotic compound DNV3837 Having reached a sufficient number of clinical centers, Phase II clinical trial testing the antibiotic...
Entasis Therapeutics Initiates Global Phase 3 Pivotal Trial of ETX2514SUL for Patients with Carbapenem-Resistant Acinetobacter Infections
April 04, 2019 08:00 ET
|
Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., April 04, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company developing novel antibacterials to treat serious...
Earth Science Tech, Inc. (ETST) Announces Strategic Partnerships to Market Hygee™ and Address Global Epidemic
January 08, 2019 08:00 ET
|
Earth Science Tech, Inc.
DORAL, Florida, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and...
Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
October 19, 2017 09:00 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the pricing...
National Patient Safety Foundation Joins with CDC and Others to Celebrate Annual Get Smart About Antibiotics Week, November 14-20, 2016
November 02, 2016 09:41 ET
|
The National Patient Safety Foundation
BOSTON, Nov. 2, 2016 (GLOBE NEWSWIRE) -- The National Patient Safety Foundation (NPSF), a central voice for patient safety since 1997, is proud to partner with the Centers for Disease Control and...
Dental Infection Control Products - Global Strategic Business Report 2013-2018
September 25, 2013 10:44 ET
|
Research and Markets
Dublin, Sept. 25, 2013 (GLOBE NEWSWIRE) -- Research and Markets
(http://www.researchandmarkets.com/research/m4mcpp/dental_infection)
has announced the addition of the
"Dental Infection...